# Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract

> **NCT00003334** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health**

## Conditions studied

- Endometrial Cancer
- Fallopian Tube Cancer
- Ovarian Cancer
- Sarcoma

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** pegylated liposomal doxorubicin hydrochloride

## Key facts

- **NCT ID:** NCT00003334
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** 2001-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2016-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003334, "Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*